Tue, February 13, 2018
Mon, February 12, 2018
Fri, February 9, 2018

Elemer Piros Maintained (ARWR) at Hold with Increased Target to $5 on, Feb 12th, 2018

Elemer Piros of Cantor Fitzgerald, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Increased Target from $2 to $5 on, Feb 12th, 2018.

Elemer has made no other calls on ARWR in the last 4 months.



There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, 0 agree with Elemer's Rating of Hold.



This is the rating of the analyst that currently disagrees with Elemer


  • Edward Tenthoff of "Piper Sandler" Upgraded from Hold to Buy on, Monday, November 27th, 2017